Periodic Reporting for period 1 - FusionPAMPs (New generation of chimeric TLR2-NOD agonist compounds for vaccine adjuvants)

New vaccine modalities need to be developed that can activate more potently the immune system, in this regard, adjuvants augment adaptive immune responses and can improve vaccine performance. Aluminum salt (alum) is the most commonly used adjuvant for human vaccination...